SELUMETINIB for Nervous system neoplasm benign: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 18 adverse event reports in the FDA FAERS database where SELUMETINIB was used for Nervous system neoplasm benign.
Most Reported Side Effects for SELUMETINIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Blood creatine phosphokinase increased | 105 | 9.0% | 1 | 7 |
| Rash | 89 | 7.6% | 0 | 13 |
| Off label use | 78 | 6.7% | 4 | 6 |
| Paronychia | 73 | 6.2% | 1 | 8 |
| Dermatitis acneiform | 61 | 5.2% | 1 | 5 |
| Diarrhoea | 59 | 5.0% | 1 | 13 |
| Fatigue | 54 | 4.6% | 1 | 9 |
| Acne | 52 | 4.4% | 0 | 5 |
| Nausea | 49 | 4.2% | 0 | 15 |
| Death | 47 | 4.0% | 47 | 0 |
| Alopecia | 45 | 3.8% | 0 | 9 |
| Vomiting | 40 | 3.4% | 1 | 11 |
| Abdominal pain | 35 | 3.0% | 0 | 5 |
| Headache | 33 | 2.8% | 1 | 9 |
| Pruritus | 31 | 2.7% | 0 | 2 |
Other Indications for SELUMETINIB
Neurofibromatosis (499)
Neurofibroma (192)
Brain neoplasm malignant (37)
Glioma (17)
Neoplasm malignant (15)
Neoplasm (14)
Non-small cell lung cancer (14)
Optic glioma (8)
Brain neoplasm (6)
Acute lymphocytic leukaemia (5)